Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic

OBJECTIVE: To study the risk of acquiring Corona Virus Disease 2019 (COVID-19) and its outcomes in patients on immunosuppressive therapy (IST) for chronic autoimmune neuromuscular disorders (aNMD) and multiple sclerosis (MS). METHODS: We used TriNetX, a global health collaborative clinical research...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Neurol Sci
Egile Nagusiak: Kovvuru, Sukanthi, Nalleballe, Krishna, Onteddu, Sanjeeva Reddy, Sharma, Rohan, Jasti, Madhu, Kapoor, Nidhi, Veerapaneni, Karthika, Yadala, Sisira, Dandu, Vasuki, Archer, Robert, Nowak, Richard J., Roy, Bhaskar
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier B.V. 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7837234/
https://ncbi.nlm.nih.gov/pubmed/33256952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jns.2020.117230
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak